v3.23.2
Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2022
Jun. 30, 2021
Cash Flows from Operating Activities        
Net loss $ (5,960,453) $ (3,878,517) $ (6,250,956) $ (24,434,336)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization of property, equipment and intangibles 543,790 387,421 560,781 490,640
Loss on disposal of property and equipment     5,878
Amortization of debt discounts 333,592 49,660 91,143 274,703
Impairment expense 46,869 195,346
Change in fair value of derivative liability 12,189 (1,842,000) (1,842,000) 1,595,388
Fair value of warrants    
Stock issued to reduce debt 1,093,223    
Extinguishment of PPP loan     310,832
Stock issued for services and donated     172,802 2,778,550
Stock issued under Equity Purchase Agreement 167,378 2,676,000 2,143,500 8,527,891
Stock issued for commitment fees     813,750
Stock issued to reduce liabilities     10,292,616
Changes in assets and liabilities:        
Accounts receivable (185,797) 206,990 413,448 (36,219)
Inventories 515,540 2,320,680 2,122,236 (2,320,155)
Intangibles (48,894)    
Right of use assets   49,222 28,539 15,931
Accounts payable 145,130 (203,221) (92,485) (973,836)
Accrued expenses 570,057 610,016 738,435 (2,158,140)
Deferred revenue (453,862) (278,426) (680,130)
Net cash used in operating activities (2,932,729) (2,755,636) (1,178,009) (6,316,265)
Cash Flows from Investing Activities        
Acquisition of business     38,846
Purchases of capitalized development costs (208,245) (363,319)    
Purchases of property and equipment (194,326) (259,307) (33,238)
Capitalization of development costs     (503,706) (508,266)
Net cash used in investing activities (208,245) (557,645) (763,013) (502,658)
Cash Flows from Financing Activities        
Principal payments on financing lease obligations 49,754 (334,956)
Principal payments on notes payable (284,685) (217,546) (518,598) (62,898)
Proceeds (payments) on notes and advances from stockholders, net (37,170) (74,026) (175,274) (16,177)
Payments on convertible notes payable     (110,000)
Proceeds from convertible notes payable 1,075,000 2,697,730
Proceeds from notes payable 1,255,935 500,000 2,490,500
Proceeds from sale of common stock under Equity Purchase Agreement 842,000 1,633,700 500,000 5,073,438
Proceeds (payments) on line of credit, net 332,281 (991,598) (991,598) (245,000)
Proceeds from notes payable-related parties     395,300 45,986
Net cash provided by financing activities 2,158,115 1,925,530 1,700,330 6,948,123
Net (Decrease) Increase in Cash and Cash Equivalents (982,859) (1,387,751) (240,692) 129,200
Cash, Beginning of Period 300,899 541,591 541,591 412,391
Cash, End of Period (681,960) (846,160) 300,899 541,591
Supplemental and Non Cash Disclosures        
Legal fees netted from loan proceeds 56,233 78,750    
Interest on shares issued under Equity Purchase Agreement 2,143,500    
Stock issued for services 238,128 110,852    
Change in fair value of derivatives   1,842,000    
Preferred stock issued in exchange for debt reduction 1,825,000    
Stock issued to convert Preferred Series F 451,977    
Noncash additions related to notes payable     53,750 228,020
Cash paid for interest 78 54,756 32,080 263,242
Related party note payable issued for acquisition of business     194,526
Acquisition of intangibles     46,869
Convertible notes and warrants extinguished     1,825,000 5,402,885
Stock issued for services and donated 335,434 (1,350,217) 172,852 2,778,550
Property leased with financing lease 97,253 97,523
Accretion of discount on notes payable     91,143 382,436
Stock issued to reduce notes payable $ 627,958 13,031,235
Common stock issued in connection with the Equity Purchase Agreement     $ 2,143,500 $ 13,601,329